Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Dana-Farber Cancer Institute · Center for Orthopaedics · +4 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
994
total citations
- FWCI
- 39.19
- Percentile
- 100%
- References
- 30
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- T790M
- EGFR inhibitors
- Epidermal growth factor receptor
- Kinase
- Quinazoline
- Mutant
- Afatinib
- Cancer research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.